10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      SASP: Tumor Suppressor or Promoter? Yes!

      1 , 2
      Trends in cancer
      Elsevier BV
      SASP, chemotherapy response, immune response, p53, senescence, tumor suppression

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cellular senescence is a permanent growth arrest in cells with damage or stress that could lead to transformation. Some tumor cells also undergo senescence in response to chemotherapy. Senescent cells secrete cytokines and other factors of the senescence-associated secretory phenotype (SASP) that contribute to tumor suppression by enforcing arrest and recruiting immune cells that remove these damaged or oncogene-expressing cells from organisms. However, some cells can develop a SASP comprising factors that are immunosuppressive and protumorigenic by paracrine mechanisms. Likewise, the SASP in treated cancers can either contribute to durable responses or drive relapse. Here, we discuss the studies that have demonstrated a complex and often conflicting role for the SASP in tumorigenesis and treatment response.

          Related collections

          Author and article information

          Journal
          Trends Cancer
          Trends in cancer
          Elsevier BV
          2405-8025
          2405-8025
          Nov 2016
          : 2
          : 11
          Affiliations
          [1 ] Tulane School of Medicine, Department of Biochemistry and Molecular Biology, 1430 Tulane Avenue #8543, New Orleans, LA 70112, USA.
          [2 ] Tulane School of Medicine, Department of Biochemistry and Molecular Biology, 1430 Tulane Avenue #8543, New Orleans, LA 70112, USA. Electronic address: jjacks8@tulane.edu.
          Article
          S2405-8033(16)30134-0
          10.1016/j.trecan.2016.10.001
          28741506
          9ed77f3d-eb5c-43c9-8424-758c5fd13620
          History

          chemotherapy response,SASP,tumor suppression,senescence,p53,immune response

          Comments

          Comment on this article